secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sanara MedTech Inc. (SMTI)
CIK:        0000714256
Form:       8-K
Filed at:   2023-08-02T23:59:59+00:00
Accession:  0001493152-23-026375
Event type: m_and_a
Sentiment:  positive
Materiality: 0.80
Item codes: 1.01, 2.01, 2.03, 3.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sanara MedTech acquires collagen assets for $15.25M; funds with $12M loan from Cadence Bank
--------------------------------------------------------------------------------

- Acquired IP, manufacturing rights, and four 510(k)-cleared products including CellerateRX and HYCOL.
- Purchase price: $9.75M cash, $3.0M in stock (73,809 shares), $2.5M in four annual installments.
- Entered $12M term loan with Cadence Bank at Term SOFR + 3%, maturing August 2028.
- Sellers eligible for up to $10M earnout based on future sales of a collagen product under development.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/714256/000149315223026375/0001493152-23-026375-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/714256/000149315223026375/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-026375

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer